Cart
sales@molnova.com
Malic acid
CAS No. 6915-15-7
Malic acid( E 296 | FDA 2018 | Hydroxybutanedioic acid )
Catalog No. M19003 CAS No. 6915-15-7
Malic acid supplementation may be useful for conservative treatment of calcium renal stone disease by virtue of its capacity to induce these effects.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 500MG | 35 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMalic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionMalic acid supplementation may be useful for conservative treatment of calcium renal stone disease by virtue of its capacity to induce these effects.
-
DescriptionMalic acid did reduce populations of L. monocytogenes on poultry. Malic acid supplementation may be useful for conservative treatment of calcium renal stone disease by virtue of its capacity to induce these effects.
-
In Vitro——
-
In Vivo——
-
SynonymsE 296 | FDA 2018 | Hydroxybutanedioic acid
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number6915-15-7
-
Formula Weight134.08
-
Molecular FormulaC4H6O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (745.77 mM)
-
SMILESC(C(C(=O)O)O)C(=O)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Quercetin 3,5,7,3,4-...
Quercetin 3,5,7,3,4-pentamethyl ether is a natural product.
-
GIP (1-30) amide (Hu...
GIP (1-30) amide (Human) TFA is a glucose-dependent insulinotropic polypeptide fragment. Glucose-dependent insulinotropic polypeptide (GIP) is an incretin hormone that stimulates insulin secretion and reduces postprandial glycaemic excursions.
-
VT-105
VT-105 is a potent and selective TEAD autopalmitoylation inhibitor that hinders proliferation and tumor growth in NF2-deficient mesotheliomas.
